Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4236 results

Sort By:

Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab

Study ID: NCT06816927
Start Date: 2025-11-01
End Date: 2031-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

92

Intervention / Treatment

Nivolumab

Relatylimab

TMZ

Radiation Therapy

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

An Observational Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

Study ID: NCT07075627
Start Date: 2025-09
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment
Sponsor

Addario Lung Cancer Medical Institute

Source: clinicaltrials.gov

Share:
Add to list

Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor

Study ID: NCT06998173
Start Date: 2025-07-31
End Date: 2028-07-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

228

Intervention / Treatment

Dat-1304 tablet

Sponsor

Danatlas Pharmaceuticals Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer

Study ID: NCT05158127
Start Date: 2025-12
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

AlloRx

Sponsor

The Foundation for Orthopaedics and Regenerative Medicine

Source: clinicaltrials.gov

Share:
Add to list

Rapid Inflation/Deflation Compared With Prolonged High-Pressure Balloon Inflation

Study ID: NCT01952873
Start Date: 2027-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Prolonged inflation

Rapid inflation

Sponsor

Central Arkansas Veterans Healthcare System

Source: clinicaltrials.gov

Share:
Add to list

ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer

Study ID: NCT06224673
Start Date: 2025-08-01
End Date: 2028-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Arch788

Computed Tomography (CT)

Biospecimen Collection

Amiloride

Sponsor

Laura Huppert, MD, BA

Source: clinicaltrials.gov

Share:
Add to list

Impact of T Cells on Age-related Vascular Dysfunction: A Translational Approach

Study ID: NCT04344873
Start Date: 2025-09-01
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

Placebo

Abatacept 10 mg/kg

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

A COPD Data Registry for Participants With Frequent Exacerbations

Study ID: NCT07059273
Start Date: 2025-09-15
End Date: 2031-02-28
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3000

Intervention / Treatment
Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

Baropodometric Patterns Associated with Metatarsalgia

Study ID: NCT06534073
Start Date: 2025-10-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

Socks

Standard device

Foot orthoses

Sponsor

University of Seville

Source: clinicaltrials.gov

Share:
Add to list

Effects of Tobacco Abuse Liability-dependent Taxes in the ETM

Study ID: NCT07042373
Start Date: 2025-12-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

51

Intervention / Treatment

Control

Product Category Score

Product Category Rank

Product Tiers

Sponsor

Virginia Polytechnic Institute and State University

Source: clinicaltrials.gov

Share:
Add to list